Summary/Review: Pathology after neoadjuvant treatment for breast cancer – How to assess residual disease.
e-ESO Podcasts - Un pódcast de ESO - European School of Oncology
Categorías:
Expert: Nicola Fusco, University of Milan and IRCCS European Institute of Oncology, Milan, IT
